Loading…
avatar for Alonza Cruse

Alonza Cruse

FDA
Director, Office of Pharmaceutical Quality Operations, ORA, OGROP
Director, Office of Pharmaceutical Quality Operations within FDA’s Office of Regulatory Affairs (ORA), responsible for all pharmaceutical quality inspections & investigations, both foreign & domestic, working in conjunction with FDA Centers: CDER and CVM. Alonza is also leading ORA’s efforts under the program alignment initiative, intended to facilitate operational and policy activities as FDA transitions to a distinct commodity-based and vertically-integrated pharmaceutical regulatory program.

My Speakers Sessions

Monday, June 25
 

11:00am

 
Tuesday, June 26
 

10:30am